![Stephen D. Gillies](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Stephen D. Gillies
Amministratore Delegato presso Provenance Biopharmaceuticals Corp.
Posizioni attive di Stephen D. Gillies
Società | Posizione | Inizio | Fine |
---|---|---|---|
Provenance Biopharmaceuticals Corp.
![]() Provenance Biopharmaceuticals Corp. Medical SpecialtiesHealth Technology Provenance Biopharmaceuticals Corp. engages in the research and development of immune therapeutics for the treatment of cancer. It offers immunocytokine technology, a drug that targets antibodies with immune-stimulating features of cytokines. The company was founded by Stephen D. Gillies and Jason M. Walsh in 2008 and is headquartered in Carlisle, MA. | Amministratore Delegato | 01/01/2008 | - |
Fondatore | 01/01/2008 | - | |
Presidente | 01/01/2008 | - | |
Delos Advisors Ltd.
![]() Delos Advisors Ltd. Investment ManagersFinance Delos Advisors Ltd (Delos Capital) is a private equity and venture capital firm founded by Lin Zheng Chen in 2014. The firm is headquartered in Hong Kong. | Consulente / Consigliere | - | - |
Storia della carriera di Stephen D. Gillies
Precedenti posizioni note di Stephen D. Gillies
Società | Posizione | Inizio | Fine |
---|---|---|---|
Damon Biotech, Inc. | Direttore Tecnico/Scientifico/R&S | - | - |
Abbott Biotech, Inc. | Direttore Tecnico/Scientifico/R&S | - | - |
APELLIS PHARMACEUTICALS, INC. | Direttore/Membro del Consiglio | 20/07/2011 | - |
Galenea Corp.
![]() Galenea Corp. Pharmaceuticals: MajorHealth Technology Galenea Corp. is an emerging biotechnology company which engaged in the discovery of novel therapies for central nervous system (CNC) and respiratory diseases. The firm is focusing initially on utilizing proprietary technologies to generate calcineurin-related treatments for schizophrenia. It also offers synaptic transmission drug discovery platform for alzheimer’s disease (AD), parkinson’s disease, huntington’s disease, epilepsy, bipolar depression, schizophrenia, autism spectrum disorders, and traumatic brain injury. The company was founded Jianzhu chen, Susumu Tonegawa, Maria Karayiorgou, and David J. Gerber in 2004 and is headquartered in Wakefield, MA. | Direttore/Membro del Consiglio | - | - |
MERCK KGAA | Corporate Officer/Principal | - | - |
Lexigen Pharmaceuticals Corp.
![]() Lexigen Pharmaceuticals Corp. Miscellaneous Commercial ServicesCommercial Services Lexigen Pharmaceuticals Corp. focuses on commercial physical and biological research. The company was founded by Stephen D. Gillies and is headquartered in Billerica, MA. | Fondatore | - | - |
Presidente | - | - | |
Potentia Pharmaceuticals, Inc.
![]() Potentia Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Potentia Pharmaceuticals, Inc. operates as a biotechnology company. It focuses on the development of novel therapeutics and drug delivery technologies to address chronic inflammatory diseases. The company was founded by Cedric Francois, David Darst, Alec Machiels and Pascal Deschatelets in 2001 and is headquartered in Crestwood, KY. | Direttore/Membro del Consiglio | - | - |
Formazione di Stephen D. Gillies
Rutgers State University of New Jersey | Doctorate Degree |
University of Massachusetts | Undergraduate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 10 |
Germania | 2 |
Hong Kong | 2 |
Posizioni
Director/Board Member | 3 |
Founder | 2 |
President | 2 |
Settori
Health Technology | 7 |
Consumer Services | 3 |
Commercial Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 2 |
---|---|
MERCK KGAA | Health Technology |
APELLIS PHARMACEUTICALS, INC. | Health Technology |
Aziende private | 7 |
---|---|
Potentia Pharmaceuticals, Inc.
![]() Potentia Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Potentia Pharmaceuticals, Inc. operates as a biotechnology company. It focuses on the development of novel therapeutics and drug delivery technologies to address chronic inflammatory diseases. The company was founded by Cedric Francois, David Darst, Alec Machiels and Pascal Deschatelets in 2001 and is headquartered in Crestwood, KY. | Health Technology |
Galenea Corp.
![]() Galenea Corp. Pharmaceuticals: MajorHealth Technology Galenea Corp. is an emerging biotechnology company which engaged in the discovery of novel therapies for central nervous system (CNC) and respiratory diseases. The firm is focusing initially on utilizing proprietary technologies to generate calcineurin-related treatments for schizophrenia. It also offers synaptic transmission drug discovery platform for alzheimer’s disease (AD), parkinson’s disease, huntington’s disease, epilepsy, bipolar depression, schizophrenia, autism spectrum disorders, and traumatic brain injury. The company was founded Jianzhu chen, Susumu Tonegawa, Maria Karayiorgou, and David J. Gerber in 2004 and is headquartered in Wakefield, MA. | Health Technology |
Provenance Biopharmaceuticals Corp.
![]() Provenance Biopharmaceuticals Corp. Medical SpecialtiesHealth Technology Provenance Biopharmaceuticals Corp. engages in the research and development of immune therapeutics for the treatment of cancer. It offers immunocytokine technology, a drug that targets antibodies with immune-stimulating features of cytokines. The company was founded by Stephen D. Gillies and Jason M. Walsh in 2008 and is headquartered in Carlisle, MA. | Health Technology |
Lexigen Pharmaceuticals Corp.
![]() Lexigen Pharmaceuticals Corp. Miscellaneous Commercial ServicesCommercial Services Lexigen Pharmaceuticals Corp. focuses on commercial physical and biological research. The company was founded by Stephen D. Gillies and is headquartered in Billerica, MA. | Commercial Services |
Damon Biotech, Inc. | Health Technology |
Abbott Biotech, Inc. | |
Delos Advisors Ltd.
![]() Delos Advisors Ltd. Investment ManagersFinance Delos Advisors Ltd (Delos Capital) is a private equity and venture capital firm founded by Lin Zheng Chen in 2014. The firm is headquartered in Hong Kong. | Finance |
- Borsa valori
- Insiders
- Stephen D. Gillies
- Esperienza